pantginis

Capitalize on Comeback Stories in Micro-Cap Biotech Stocks :: The …

Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]

5 Biotech Stocks Roth Capital Analysts Are Watching – Celldex …

Related CLDXWhy Cowen & Co Likes Celldex Therapeutics Following Its FDA ‘Breakthrough’Biotech Stocks Moving HigherCelldex Therapeutics(Investor’s Business Daily)Related BLRXMorning Market GainersBenzinga’s Top #PreMarket GainersRoth Capital Weighs In On 5 Biotech Stocks To Watch(Seeking Alpha)As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.”Though […]